Pharmacy- Page 188

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Approval of an Additional Indication of ACTOS in Japan

The FINANCIAL -- Takeda Pharmaceutical Company Limited (“Takeda”) announced on December 22 that an additional indication of concomitant therapy with biguanides for ACTOS (pioglitazone hydrochloride), medicine for type 2 diabetes, was approved on December 22 by the Ministry of Health, Labour and Welfare.

by The FINANCIAL

December 22, 2008

1 min read

Pharmacy

Sanofi-aventis and Novozymes announce a development and commercialization collaboration

The FINANCIAL -- Sanofi-aventis announced on December 22 the signature of a global licensing and collaboration agreement with Novozymes for the development and marketing of a potential new antibiotic.

by The FINANCIAL

December 22, 2008

1 min read

Pharmacy

FDA Approves LUSEDRA Injection for Monitored Anesthesia Care (MAC) Sedation

The FINANCIAL -- Eisai Corporation of North America on December 14 announced that the U.S. Food and Drug Administration (FDA) has approved LUSEDRA (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.

by The FINANCIAL

December 15, 2008

1 min read

Pharmacy

Sanofi-aventis was granted the 2008 China Charity Award

The FINANCIAL -- Sanofi-aventis announced on December 15 that it was granted the “2008 China Charity Award” by the Ministry of Civil Affairs of the People’s Republic of China.

by The FINANCIAL

December 15, 2008

1 min read

Pharmacy

DOXIL Combination Therapy Delays Disease Progression for Patients with Metastatic Breast Cancer

The FINANCIAL -- Results from a Phase 3 study show that patients with metastatic breast cancer who were treated previously with an anthracycline in the adjuvant setting experienced a significant improvement in time to disease progression (TTP) and overall response rates after

by The FINANCIAL

December 15, 2008

1 min read

Pharmacy

Results of Two Large Phase III Trials (CLL8 and REACH)

The FINANCIAL -- Genentech, Inc. (NYSE: DNA) and Biogen Idec (Nasdaq: BIIB) on December 6 announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan (rituximab) plus chemotherapy significantly increased the time patients lived without their disease

by The FINANCIAL

December 8, 2008

2 mins read

Pharmacy

DAIICHI SANKYO Initiates Phase III Trial of its Investigational Factor Xa Inhibitor, DU-176b

The FINANCIAL -- Patients with non-valvular atrial fibrillation receiving either 30 mg or 60 mg once-daily dose of DU-176b, an investigational oral Factor Xa inhibitor, experienced comparable safety and tolerability compared to those taking warfarin, according to new Phase II data presented

by The FINANCIAL

December 8, 2008

1 min read

Pharmacy

Jonathan Knowles to retire from Roche at the end of 2009

The FINANCIAL -- Prof. Jonathan Knowles, Head of Group Research and member of the Corporate Executive Committee of Roche, will retire from Roche at the end of 2009. During 2009, he will facilitate a smooth transition of his responsibilities to Lee Babiss,

by The FINANCIAL

December 8, 2008

1 min read

Pharmacy

Merck Reaffirms Cardiovascular Research Commitment

The FINANCIAL -- Merck & Co., Inc. on December 8 reaffirmed its commitment to discovering and developing novel treatments for a broad range of cardiovascular disorders, including atherosclerosis, hypertension, heart failure and metabolic syndrome. This year marks the 50th anniversary of the launch of

by The FINANCIAL

December 8, 2008

2 mins read

Pharmacy

GlaxoSmithKline Says Promacta Elevates Platelet Count In Chronic ITP Patients

The FINANCIAL -- GlaxoSmithKline (GSK) on December 6 presented positive safety and efficacy results from RAISE (RAndomised placebo-controlled ITP Study with Eltrombopag), a Phase III study of Promacta/Revolade (eltrombopag) in adults with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who had received one or more

by The FINANCIAL

December 8, 2008

3 mins read